Comparison of side effect of survanta and curosurf in decreasing mortality due to respiratory distress syndrome (RDS) in premature infants admitted in NICU of Ghaem Hospital on 2006-2008

Iranian Journal of Neonatology

Volumn 4, Issue 3, 2013, Pages 7-12

  Reza, S ^a   Abdolkarim, Hamedi ^a   Ali, Javadi ^a   Mahbobeh, Gholami Robatsangi ^a   Shima, Kaka Dinparvar ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Neonates; Respiratory distress syndrome; Surfactant

Indexed keywords

BERACTANT; PORACTANT;

ARTICLE; ASSISTED VENTILATION; BIRTH WEIGHT; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN DEATH; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; PATENT DUCTUS ARTERIOSUS; PNEUMOTHORAX; PREMATURITY; TREATMENT RESPONSE;

EID: 84980053685     PISSN: 22517510     EISSN: 23222158     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Slattery MM, Morrison JJ. Preterm delivery.Lancet .2002; 360: 1489-1497
2. Callaghan WM, MacDorman MF, Rasmussen SA, Qin C, Lackritz EM. The contribution of preterm birth to infant mortality in the United States. Pediatrics. 2006; 118: 1566-1573
3. Lemons JA, Bauer CR, Oh W, Korones S, et al. Very low birth weight infant outcomes of the NICHD Neonatal Research Network. Pediatrics .2001; 107:1-8
4. Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K. A randomized, multicenter masked comparison trial of poractant alpha (curosurf) versus beractant (survanta) in the treatment of Respiratory distress syndrome in preterm infants. Am J Perinatol .2004; 21:109-119
5. Lewis JF, Brackenbury A. Role of exogenous surfactant in acute lung injury.Crit Care Med. 2003; 31: 324-328
6. Speer CP, Gefeller O, Groneck P, Laufkotter E, Roll C, Hanssler L, et al. Randomized clinical trial of two treatment regimens of natural surfactant Preparations in neonatal respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 1995; 72: 8-13
7. Baroutis G, Kaleyias J, Liarou T, Papathoma E, Hatzistamatiou Z, Costalos C. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr 2003; 162:476-480
8. Malloy CA, Nicoski P, Muraskas JM. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome. ActaPaediatr. 2005; 94: 779-784
9. Marsh W, Smeeding J, York JM, Ramanathan R, Sekar K. A cost minimization comparison of two surfactants, beractant and poractant alpha, based upon prospectively designed, comparative clinical trial data. J Pediatr Pharmacol Ther. 2004; 9: 113-121.